Keros Therapeutics, Inc. Increase (Decrease) in Accrued Taxes Payable
Keros Therapeutics, Inc. (KROS) reported Increase (Decrease) in Accrued Taxes Payable of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedTaxesPayable · last filed 2026-08-03
- Keros Therapeutics, Inc. increase (decrease) in accrued taxes payable for the quarter ending 2026-06-30 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in accrued taxes payable for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Keros Therapeutics, Inc. increase (decrease) in accrued taxes payable for the quarter ending 2025-09-30 was -$2.17M.
- Keros Therapeutics, Inc. increase (decrease) in accrued taxes payable for the quarter ending 2025-06-30 was -$3.72M.
| Period end | Increase (Decrease) in Accrued Taxes Payable 3 month | Increase (Decrease) in Accrued Taxes Payable 6 month | Increase (Decrease) in Accrued Taxes Payable 9 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | ||
| 2025-09-30 | -$2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$5.90M derived: sum of 2 quarters · filed 2026-08-03 | $4.15M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $6.32M 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $10.04M 10-Q · filed 2026-05-14 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |